Financhill
Sell
39

JUSH.CX Quote, Financials, Valuation and Earnings

Last price:
$0.89
Seasonality move :
-7.25%
Day range:
$0.83 - $0.90
52-week range:
$0.34 - $1.33
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.46x
P/B ratio:
--
Volume:
87.1K
Avg. volume:
204K
1-year change:
88.89%
Market cap:
$167.2M
Revenue:
$352.8M
EPS (TTM):
-$0.47

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
JUSH.CX
Jushi Holdings, Inc.
$94.5M -$0.10 2.63% -10.86% $1.52
DRUG.CX
Bright Minds Biosciences, Inc.
-- -$1.40 -- -483.33% $78.00
FFNT.CX
4Front Ventures Corp.
-- -- -- -- --
GTII.CX
Green Thumb Industries, Inc.
$407.3M -$0.01 -1.05% -100% $17.51
LOWL.CX
Lowell Farms, Inc.
-- -- -- -- --
WESA.X.CX
Wesana Health Holdings
-- -- -- -- --
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
JUSH.CX
Jushi Holdings, Inc.
$0.85 $1.52 $167.2M -- $0.00 0% 0.46x
DRUG.CX
Bright Minds Biosciences, Inc.
$110.43 $78.00 $859.9M -- $0.00 0% --
FFNT.CX
4Front Ventures Corp.
$0.0050 -- $4.6M -- $0.00 0% 0.04x
GTII.CX
Green Thumb Industries, Inc.
$11.02 $17.51 $2.6B 42.71x $0.00 0% 1.61x
LOWL.CX
Lowell Farms, Inc.
$0.02 -- $272.2K -- $0.00 0% 0.01x
WESA.X.CX
Wesana Health Holdings
$0.0100 -- $200.8K -- $0.00 0% 0.39x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
JUSH.CX
Jushi Holdings, Inc.
158.69% -2.465 194.08% 0.22x
DRUG.CX
Bright Minds Biosciences, Inc.
0.15% 2.580 0.02% 35.50x
FFNT.CX
4Front Ventures Corp.
338.18% 0.857 156.19% 0.11x
GTII.CX
Green Thumb Industries, Inc.
22.08% 0.404 27.9% 1.19x
LOWL.CX
Lowell Farms, Inc.
-- 0.285 -- 0.35x
WESA.X.CX
Wesana Health Holdings
-- -3.241 -- --
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
JUSH.CX
Jushi Holdings, Inc.
$36M $3.2M -32.89% -897.34% 3.56% $1.1M
DRUG.CX
Bright Minds Biosciences, Inc.
-$17K -$5.7M -24.1% -24.17% -- -$1.3M
FFNT.CX
4Front Ventures Corp.
$5M -$8.9M -137.74% -- -25.23% -$770.6K
GTII.CX
Green Thumb Industries, Inc.
$189.3M $50.6M 1.96% 2.53% 12.61% $78.2M
LOWL.CX
Lowell Farms, Inc.
-$1.3M -$2.9M -130.79% -182.5% -99.38% -$1.2M
WESA.X.CX
Wesana Health Holdings
-- -- -- -- -- --

Jushi Holdings, Inc. vs. Competitors

  • Which has Higher Returns JUSH.CX or DRUG.CX?

    Bright Minds Biosciences, Inc. has a net margin of -36.07% compared to Jushi Holdings, Inc.'s net margin of --. Jushi Holdings, Inc.'s return on equity of -897.34% beat Bright Minds Biosciences, Inc.'s return on equity of -24.17%.

    Company Gross Margin Earnings Per Share Invested Capital
    JUSH.CX
    Jushi Holdings, Inc.
    39.82% -$0.17 $240.6M
    DRUG.CX
    Bright Minds Biosciences, Inc.
    -- -$0.57 $82.2M
  • What do Analysts Say About JUSH.CX or DRUG.CX?

    Jushi Holdings, Inc. has a consensus price target of $1.52, signalling upside risk potential of 78.43%. On the other hand Bright Minds Biosciences, Inc. has an analysts' consensus of $78.00 which suggests that it could fall by -30.27%. Given that Jushi Holdings, Inc. has higher upside potential than Bright Minds Biosciences, Inc., analysts believe Jushi Holdings, Inc. is more attractive than Bright Minds Biosciences, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    JUSH.CX
    Jushi Holdings, Inc.
    3 1 0
    DRUG.CX
    Bright Minds Biosciences, Inc.
    6 0 0
  • Is JUSH.CX or DRUG.CX More Risky?

    Jushi Holdings, Inc. has a beta of 0.702, which suggesting that the stock is 29.81% less volatile than S&P 500. In comparison Bright Minds Biosciences, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock JUSH.CX or DRUG.CX?

    Jushi Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Bright Minds Biosciences, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Jushi Holdings, Inc. pays -- of its earnings as a dividend. Bright Minds Biosciences, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios JUSH.CX or DRUG.CX?

    Jushi Holdings, Inc. quarterly revenues are $90.5M, which are larger than Bright Minds Biosciences, Inc. quarterly revenues of --. Jushi Holdings, Inc.'s net income of -$32.6M is lower than Bright Minds Biosciences, Inc.'s net income of -$4.1M. Notably, Jushi Holdings, Inc.'s price-to-earnings ratio is -- while Bright Minds Biosciences, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Jushi Holdings, Inc. is 0.46x versus -- for Bright Minds Biosciences, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    JUSH.CX
    Jushi Holdings, Inc.
    0.46x -- $90.5M -$32.6M
    DRUG.CX
    Bright Minds Biosciences, Inc.
    -- -- -- -$4.1M
  • Which has Higher Returns JUSH.CX or FFNT.CX?

    4Front Ventures Corp. has a net margin of -36.07% compared to Jushi Holdings, Inc.'s net margin of -37.38%. Jushi Holdings, Inc.'s return on equity of -897.34% beat 4Front Ventures Corp.'s return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    JUSH.CX
    Jushi Holdings, Inc.
    39.82% -$0.17 $240.6M
    FFNT.CX
    4Front Ventures Corp.
    21.39% -$0.01 $27.7M
  • What do Analysts Say About JUSH.CX or FFNT.CX?

    Jushi Holdings, Inc. has a consensus price target of $1.52, signalling upside risk potential of 78.43%. On the other hand 4Front Ventures Corp. has an analysts' consensus of -- which suggests that it could grow by 2907.29%. Given that 4Front Ventures Corp. has higher upside potential than Jushi Holdings, Inc., analysts believe 4Front Ventures Corp. is more attractive than Jushi Holdings, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    JUSH.CX
    Jushi Holdings, Inc.
    3 1 0
    FFNT.CX
    4Front Ventures Corp.
    0 0 0
  • Is JUSH.CX or FFNT.CX More Risky?

    Jushi Holdings, Inc. has a beta of 0.702, which suggesting that the stock is 29.81% less volatile than S&P 500. In comparison 4Front Ventures Corp. has a beta of 0.809, suggesting its less volatile than the S&P 500 by 19.082%.

  • Which is a Better Dividend Stock JUSH.CX or FFNT.CX?

    Jushi Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. 4Front Ventures Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Jushi Holdings, Inc. pays -- of its earnings as a dividend. 4Front Ventures Corp. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios JUSH.CX or FFNT.CX?

    Jushi Holdings, Inc. quarterly revenues are $90.5M, which are larger than 4Front Ventures Corp. quarterly revenues of $23.4M. Jushi Holdings, Inc.'s net income of -$32.6M is lower than 4Front Ventures Corp.'s net income of -$8.7M. Notably, Jushi Holdings, Inc.'s price-to-earnings ratio is -- while 4Front Ventures Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Jushi Holdings, Inc. is 0.46x versus 0.04x for 4Front Ventures Corp.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    JUSH.CX
    Jushi Holdings, Inc.
    0.46x -- $90.5M -$32.6M
    FFNT.CX
    4Front Ventures Corp.
    0.04x -- $23.4M -$8.7M
  • Which has Higher Returns JUSH.CX or GTII.CX?

    Green Thumb Industries, Inc. has a net margin of -36.07% compared to Jushi Holdings, Inc.'s net margin of 8.17%. Jushi Holdings, Inc.'s return on equity of -897.34% beat Green Thumb Industries, Inc.'s return on equity of 2.53%.

    Company Gross Margin Earnings Per Share Invested Capital
    JUSH.CX
    Jushi Holdings, Inc.
    39.82% -$0.17 $240.6M
    GTII.CX
    Green Thumb Industries, Inc.
    47.18% $0.14 $3.3B
  • What do Analysts Say About JUSH.CX or GTII.CX?

    Jushi Holdings, Inc. has a consensus price target of $1.52, signalling upside risk potential of 78.43%. On the other hand Green Thumb Industries, Inc. has an analysts' consensus of $17.51 which suggests that it could grow by 58.92%. Given that Jushi Holdings, Inc. has higher upside potential than Green Thumb Industries, Inc., analysts believe Jushi Holdings, Inc. is more attractive than Green Thumb Industries, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    JUSH.CX
    Jushi Holdings, Inc.
    3 1 0
    GTII.CX
    Green Thumb Industries, Inc.
    9 1 0
  • Is JUSH.CX or GTII.CX More Risky?

    Jushi Holdings, Inc. has a beta of 0.702, which suggesting that the stock is 29.81% less volatile than S&P 500. In comparison Green Thumb Industries, Inc. has a beta of 0.830, suggesting its less volatile than the S&P 500 by 17.046%.

  • Which is a Better Dividend Stock JUSH.CX or GTII.CX?

    Jushi Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Green Thumb Industries, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Jushi Holdings, Inc. pays -- of its earnings as a dividend. Green Thumb Industries, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios JUSH.CX or GTII.CX?

    Jushi Holdings, Inc. quarterly revenues are $90.5M, which are smaller than Green Thumb Industries, Inc. quarterly revenues of $401.3M. Jushi Holdings, Inc.'s net income of -$32.6M is lower than Green Thumb Industries, Inc.'s net income of $32.8M. Notably, Jushi Holdings, Inc.'s price-to-earnings ratio is -- while Green Thumb Industries, Inc.'s PE ratio is 42.71x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Jushi Holdings, Inc. is 0.46x versus 1.61x for Green Thumb Industries, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    JUSH.CX
    Jushi Holdings, Inc.
    0.46x -- $90.5M -$32.6M
    GTII.CX
    Green Thumb Industries, Inc.
    1.61x 42.71x $401.3M $32.8M
  • Which has Higher Returns JUSH.CX or LOWL.CX?

    Lowell Farms, Inc. has a net margin of -36.07% compared to Jushi Holdings, Inc.'s net margin of -111.87%. Jushi Holdings, Inc.'s return on equity of -897.34% beat Lowell Farms, Inc.'s return on equity of -182.5%.

    Company Gross Margin Earnings Per Share Invested Capital
    JUSH.CX
    Jushi Holdings, Inc.
    39.82% -$0.17 $240.6M
    LOWL.CX
    Lowell Farms, Inc.
    -28.98% -$0.26 $5.7M
  • What do Analysts Say About JUSH.CX or LOWL.CX?

    Jushi Holdings, Inc. has a consensus price target of $1.52, signalling upside risk potential of 78.43%. On the other hand Lowell Farms, Inc. has an analysts' consensus of -- which suggests that it could grow by 19875.27%. Given that Lowell Farms, Inc. has higher upside potential than Jushi Holdings, Inc., analysts believe Lowell Farms, Inc. is more attractive than Jushi Holdings, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    JUSH.CX
    Jushi Holdings, Inc.
    3 1 0
    LOWL.CX
    Lowell Farms, Inc.
    0 0 0
  • Is JUSH.CX or LOWL.CX More Risky?

    Jushi Holdings, Inc. has a beta of 0.702, which suggesting that the stock is 29.81% less volatile than S&P 500. In comparison Lowell Farms, Inc. has a beta of 1.817, suggesting its more volatile than the S&P 500 by 81.733%.

  • Which is a Better Dividend Stock JUSH.CX or LOWL.CX?

    Jushi Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Lowell Farms, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Jushi Holdings, Inc. pays -- of its earnings as a dividend. Lowell Farms, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios JUSH.CX or LOWL.CX?

    Jushi Holdings, Inc. quarterly revenues are $90.5M, which are larger than Lowell Farms, Inc. quarterly revenues of $4.4M. Jushi Holdings, Inc.'s net income of -$32.6M is lower than Lowell Farms, Inc.'s net income of -$5M. Notably, Jushi Holdings, Inc.'s price-to-earnings ratio is -- while Lowell Farms, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Jushi Holdings, Inc. is 0.46x versus 0.01x for Lowell Farms, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    JUSH.CX
    Jushi Holdings, Inc.
    0.46x -- $90.5M -$32.6M
    LOWL.CX
    Lowell Farms, Inc.
    0.01x -- $4.4M -$5M
  • Which has Higher Returns JUSH.CX or WESA.X.CX?

    Wesana Health Holdings has a net margin of -36.07% compared to Jushi Holdings, Inc.'s net margin of --. Jushi Holdings, Inc.'s return on equity of -897.34% beat Wesana Health Holdings's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    JUSH.CX
    Jushi Holdings, Inc.
    39.82% -$0.17 $240.6M
    WESA.X.CX
    Wesana Health Holdings
    -- -- --
  • What do Analysts Say About JUSH.CX or WESA.X.CX?

    Jushi Holdings, Inc. has a consensus price target of $1.52, signalling upside risk potential of 78.43%. On the other hand Wesana Health Holdings has an analysts' consensus of -- which suggests that it could grow by 2383.25%. Given that Wesana Health Holdings has higher upside potential than Jushi Holdings, Inc., analysts believe Wesana Health Holdings is more attractive than Jushi Holdings, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    JUSH.CX
    Jushi Holdings, Inc.
    3 1 0
    WESA.X.CX
    Wesana Health Holdings
    0 0 0
  • Is JUSH.CX or WESA.X.CX More Risky?

    Jushi Holdings, Inc. has a beta of 0.702, which suggesting that the stock is 29.81% less volatile than S&P 500. In comparison Wesana Health Holdings has a beta of -1.000, suggesting its less volatile than the S&P 500 by 200.004%.

  • Which is a Better Dividend Stock JUSH.CX or WESA.X.CX?

    Jushi Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Wesana Health Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Jushi Holdings, Inc. pays -- of its earnings as a dividend. Wesana Health Holdings pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios JUSH.CX or WESA.X.CX?

    Jushi Holdings, Inc. quarterly revenues are $90.5M, which are larger than Wesana Health Holdings quarterly revenues of --. Jushi Holdings, Inc.'s net income of -$32.6M is higher than Wesana Health Holdings's net income of --. Notably, Jushi Holdings, Inc.'s price-to-earnings ratio is -- while Wesana Health Holdings's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Jushi Holdings, Inc. is 0.46x versus 0.39x for Wesana Health Holdings. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    JUSH.CX
    Jushi Holdings, Inc.
    0.46x -- $90.5M -$32.6M
    WESA.X.CX
    Wesana Health Holdings
    0.39x -- -- --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Stan Druckenmiller Sell Broadcom Stock?
Why Did Stan Druckenmiller Sell Broadcom Stock?

In Q3, legendary macro investor Stan Druckenmiller sold his entire…

Why Is CoreWeave Stock Down So Much?
Why Is CoreWeave Stock Down So Much?

AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…

Why Did Stan Druckenmiller Buy MercadoLibre Stock?
Why Did Stan Druckenmiller Buy MercadoLibre Stock?

In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…

Stock Ideas

Buy
55
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Sell
30
CORT alert for Jan 2

Corcept Therapeutics, Inc. [CORT] is up 6.15% over the past day.

Buy
75
AXSM alert for Jan 2

Axsome Therapeutics, Inc. [AXSM] is down 3.84% over the past day.

Sell
50
NUTX alert for Jan 2

Nutex Health, Inc. [NUTX] is down 10.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock